Skip to main content
 

Bodyport

Bodyport

Bodyport™ is a biomarker-guided digital therapeutics company addressing complex chronic conditions by delivering actionable insights gleaned from unique health signals and simple, at-home experiences. The company is tackling heart failure first with its Bodyport for Heart Health solution, to noninvasively assess heart function and fluid status at home via our Cardiac Scale, providing patients and their care teams comprehensive insights to tailor therapeutic actions and personalized insights — keeping people living with heart failure healthier and out of the hospital.

More News

  • Home-Time, Mortality, and Readmissions Among Patients Hospitalized With Heart Failure: A Baseline Prior to IMPLEMENT-HF

  • AHA Innovators’ Network Member Accurkardia receives FDA Breakthrough Device Designation on New Condition Area

  • Target: BP™ initiative helps more than 9M Americans with hypertension